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As has been found by one ofus (Zondek, 1952), people suffering from essential
hypertension have a lesser inclination to cancer than people with normal blood
pressure; essential hypertension has been assumed to have an inhibiting influence
on cancer, i.e., it may prevent development of cancer altogether or postpone its
occurrence for years or even decades. The negative relationship existing between
the two diseases includes both sexes, but has been found to be more marked in
men than in women; and in the latter, in some groups of cancer, i.e., those of
the sexual organs and breast, the negative relationship, if existing at all, can
hardly be regarded as a significant one.
The incidence of carcinoma being much greater than that of sarcoma, cases
of the former only were subjected to the investigations quoted above. Mean-
while, we took the opportunity of examining sarcoma, too; moreover, leukaemia
was included, since this disease is now regarded by most of the authoritative
workers (Rohr, 1949), as also belonging to the group of malignant diseases.
Compared with the number of cases of carcinoma which were the subject of the
previous examinations, the number for sarcoma and leukaemia we have examined
is rather small, i.e., 237 cases; but, for the following reasons, we should be entitled
to report on them.
(1.) The patients with sarcoma and leukaemia we have examined include not
only the material at present under observation in the main hospitals of this
country, but comprise also most of the hospital cases observed during the last
5-10 years; considering the comparatively low incidence of sarcoma and leu-
kaemia, we shall hardly be able to report on a much greater material in the near
future.
(2) The result of our examinations, even based on this number of cases, is,
in our opinion, unequivocal and all the more convincing as it corresponds to our
expectations, i.e., inprinciple it fits in with the result ofthe examinations obtained
in the cases of carcinoma.
(3) Our findings may encourage other workers who have at their disposal
much more material, for this study.
The investigations on carcinoma were, of course, continued. While the data
of the carcinoma cases, to which the first publication referred, to a considerable
extent were gained from the case reports we had obtained from various hospitals,
most of the new cases were examined by us and with the precautions necessary
for a reliable estimation of blood pressure (repeated examinations on successive
days). As to the particulars of the diagnosis of essential hypertension we refer
the reader to the first publication (Zondek, 1952). Moreover, in a not too small
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which were made during theyears priorto the onset ofcancer, The newinvestiga-
tions are not only in full accordance with those reported in the first publication,
their result is even more pronounced. Thus, in the male patients, aged 40 and
more, among the 100 newly examined cases of carcinoma of the intestinal tract,
pancreas, liver, gall bladder and those of the respiratory tract only 3, i.e., 3 per
cent were found to suffer from essential hypertension. This result is the more
remarkable, since the greater proportion of these patients, i.e., 87, belong to the
age group of over 50 years with a usual incidence of hypertension of 20-25 per
cent. In 33 of the 100 new carcinoma cases the blood pressure which existed
before the appearance of the malignant disease, could be ascertained; essential
hypertension was found in only 2 cases. For obvious reasons, cases of malig-
nancy where the blood pressure before the onset ofthe disease can be ascertained,
may be the most reliable with regard to the problem we are dealing with, as has
been explained in the previous publication. It should, however, be realised that
statistics based on this principle may indicate a higher incidence of hypertension
in cases ofmalignancy than it really amounts to; for it can reasonably be assumed
that the chance that blood pressure had been estimated in the past is greater in
hypertension cases than in others; on the other hand, the mere assertion of a
patient of having always enjoyed good health can not be held sufficient to include
him in these special statistics.
A summary review of the essential findings concerning carcinoma cases is
given in Table I; this review may also serve a better understanding ofour findings
in sarcoma, and leukaemia. The carcinoma cases comprise those which were
elaborated in the previous publications plus the newly examined cases.
TABLE I.-Cancer in Men (720 cases).
Hypertension Hypertension
found in found in Usual
various forms cancer of the incidence of
of cancer intestinal tract hypertension
Age-group. (%). (%). (%).
40-49 . 49 . 14 . 103-12-6
50-59 4.9 . 3-8 . 205-22-0
60-69 . 12-2* . 12-1* . 266-30 0
70 and over. 13-0 . 90 . 32-6-30-0
* According to the new examinations this figure seems to be too high.
Cancer in Women (1148 cases).
Hypertension
found in
various forms Hypertension
of cancer, found in Usual
excluding breast cancer of incidence of
and genitals breast hypertension
Age-group. (%). (%). (%).
40-49 . 2-7 . 10*0 . 13*3-16-7
50-59 . 16-7 . 22-2 . 240-31-0
60-69 . 30.3 . 32-1 . 29-0-42 0
70andover. 3850 . 50.0 . 340-53 0
As to the evaluation of the findings we refer to the previous publication
(Zondek, 1952), but itmay be again stressed that some groups ofcarcinoma deviate
altogether from the general line; e.g., in carcinoma of the breast, as seen in
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Table I, incidence of essential hypertension is so close to the figure, which has
been assessed by us as the normal incidence and which naturally can only be
regarded as approximately exact (Zondek, 1952) that the rate for hypertension
found in cases of cancer of the breast could with some right also be regarded as
its normal incidence in women.
Our material is numerically not large enough for us to decide, whether or
not in men too, carcinoma of the sexual organs, such as testes and prostate,
deviate from the general line. Moreover, in men as well as in women, tumours
of the kidney may require special consideration and elaboration, since tumour of
the kidney by itself (as in the Goldblatt-kidney) may produce hypertension,
i.e., hypertension found in a case of kidney tumour does not automatically prove
that it was a patient with essential hypertension who developed cancer. There-
fore, only cases where the rate of blood pressure existing prior to the onset of the
malignant kidney disease can be ascertained, should be considered suitable for
the statistical elaboration.
As in the case ofcarcinoma, in sarcoma and leukaemia too, only those patients
were considered suitable for our investigation, whose general condition was still
satisfactory; cases with considerable anaemia andthose withelevated temperature
were automatically excluded; accordingly, as far as leukaemia is concerned,
the big majority of the cases elaborated in our statistics were of the chronic type.
On the other hand, cases of sarcoma and leukaemia, irrespective of their general
condition, were included in the statistics when the blood pressure existing before
the onset of the malignant disease was known (i.e., testified by the attending
physician).
The sarcoma cases comprise the various forms of sarcoma (including melanotic
sarcoma and multiple myeloma); the cases of leukaemia were nearly all of the
lymphatic or myelogenous type.
The number of cases not being large enough, a separate statistical elaboration
for both sarcomaand leukaemia and arranged according to agegroups indecades-
as has been done in the cases of carcinoma-did not seem expedient; our statis-
tics comprise both diseases with several age groups lumped together (Table II).
TABLE II.-Sarcoma and Leukaemia in Men.
Usual
Hypertension incidence of
Number found hypertension
Age-group. of cases. (%). (%).
40-69 . 133 . 3-0 . 18-20
Sarcoma and Leukaemia in Women.
Usual
Hypertension incidence of
Number found hypertension
Age-group. of cases. (%). (%).
40-59 62 . 8-0 18-24
Nevertheless, the rough figures for every decade and for every group of the
two diseases shall be reported, too. (Table III).
In 38 of the reported cases of men suffering from sarcoma or leukaemia the
blood pressure which had existed prior to the appearance of the malignant disease
could be ascertained; in only 1 case hypertension was present.
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TABLE III.
Sarcoma in Men. Leukaemia in Men.
Hypertension Hypertension
Number found Number found
Age-group. of cases. (in numbers). of cases. (in numbers).
40-49 . 24 1 . 22 Nil
50-59 . 23 1 . 27 1
60-69 . 23 1 . 15 Nil
70 and over. 4 1 . 9 1
Sarcoma in Women. Leukaemia in Women.
Hypertension Hypertension
Number found Number found
Age-groups. of cases. (in numbers). of cases. (in numbers).
40-49 . 17 1 . 13 Nil
50-59 . 16 2 . 15 2
60-69 . 10 1 . 9 3
70 and over . 5 2 . 5 1
As our examinations have proved, sarcoma as well as leukaemia do not in
principle differ from carcinoma in their relationship to essential hypertension.
In both sarcoma and leukaemia, as in carcinoma, the inhibiting influence ofessen-
tial hypertension on the development of the disease is more marked in men than
in women; while in the latter it is apparently no longer in force beyond the age
of 59, in men it is not only stronger but still makes itself felt in the age group
60-69. In view of the paucity of our material we cannot state whether or not
an inhibiting influence is present even beyond the age of 70. Moreover, it should
be stressed that in any case patients over 70 (this naturally applies also to cases
ofcarcinoma) are not very suitable for our investigations, because in this age-group
the level of blood pressure very often is too much influenced by common arterio-
sclerosis; therefore, in many cases we face great difficulties in deciding whether
a case with hypertension belongs to the group of pure common arteriosclerosis
or essential hypertension combined with arteriosclerosis.
DISCUSSION.
It should not be surprising that the relationship, existing between carcinoma
and essential hypertension has been found also in the cases of sarcoma, and the
fact that leukaemia behaves in the same way may serve as further evidence that
leukaemia, too, is a malignant tumour. However, our findings with regard to
leukaemia may have also some other importance. As Zondek (1953) has pointed
out it should d priori, be assumed that antagonisms must play a decisive part
in pathology, no less than in physiology and the whole realm of biology. As to
the biological antagonism existing between malignant growth and essential hyper-
tension the question had been raised whether certain substances, which may be
important for the development of cancer and essential hypertension may not
have a mode of action characterized by mutual inhibition or competition. These
substances in question are certainly not known, as yet; but for an eventual
examination of the substances possibly being active in essential hypertension,
with regard to their inhibiting action on malignant growth, leukaemia can be422 S. G. ZONDEK AND M. TCHETCHIK
assumed to be a better test than cancer. Moreover, Zondek's hypothesis, like-
wise based on the conception of " antagonisms in pathology," that malignant
tumours, or people with malignant tumours might be expected to harbour
compounds of pharmacodynamic action and being useful in the treatment of
other diseases, is, of course, to be applied to leukaemia as well.
SUMMARY.
People suffering from essential hypertension have a lesser inclination to sar-
coma and leukaemia than people with normal blood pressure. In principle,
the relationship existing between sarcoma orleukaemia and essential hypertension
does not differ from that found between carcinoma and essential hypertension
and referred to in a previous publication.
As in carcinoma, in sarcoma and leukaemia too, the negative relationship
between them and essential hypertension, is more marked in men than in women.
Some special questions relating to malignant growth and essential hyperten-
sion have been discussed inthelight ofthe conception ofantagonismsinpathology.
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